4.8 Article

Multiplexed DNA-Directed Patterning of Antibodies for Applications in Cell Subpopulation Analysis

期刊

ACS APPLIED MATERIALS & INTERFACES
卷 13, 期 39, 页码 46421-46430

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acsami.1c15047

关键词

DNA-directed patterning; antibody patterning; photolithography; cell capture; node-pore sensing; cell surface markers; breast cancer

资金

  1. NIH/NCI [1F32CA243354-01, 1R01CA190843-01]
  2. NIH NIH/NIBIB [1R01EB024989-01]
  3. National Science Foundation Graduate Research Fellowship
  4. Siebel Scholarship
  5. PEO Scholarship
  6. Berkeley Fellowship
  7. Ralph A. Seban Heat Transfer Fellowship

向作者/读者索取更多资源

This research developed a high-throughput method to assemble multiple distinct antibodies through microfabricated DNA patterns, enabling the functionality of antibodies in cell capture and label-free surface marker screening. This versatile technique allows for rapid development of customized antibody-based assays across a range of diverse diseases and research focuses.
Antibodies provide the functional biospecificity that has enabled the development of sensors, diagnostic tools, and assays in both laboratory and clinical settings. However, as multimarker screening becomes increasingly necessary due to the heterogeneity and complexity of human pathology, new methods must be developed that are capable of coordinating the precise assembly of multiple, distinct antibodies. To address this technological challenge, we engineered a bottom-up, high-throughput method in which DNA patterns, comprising unique 20-base pair oligonucleotides, are patterned onto a substrate using photolithography. These microfabricated surface patterns are programmed to hybridize with, and instruct the multiplexed assembly of, antibodies conjugated with the complementary DNA strands. We demonstrate that this simple, yet robust, approach preserves the antibody-binding functionality in two common applications: antibody-based cell capture and label-free surface marker screening. Using a simple proofof-concept capture device, we achieved high purity separation of a breast cancer cell line, MCF-7, from a blood cell line, Jurkat, with capture purities of 77.4% and 96.6% when using antibodies specific for the respective cell types. We also show that antigen-antibody interactions slow cell trajectories in flow in the next-generation microfluidic node-pore sensing (NPS) device, enabling the differentiation of MCF-7 and Jurkat cells based on EpCAM surface-marker expression. Finally, we use a next-generation NPS device patterned with antibodies against E-cadherin, N-cadherin, and beta-integrin-three markers that are associated with epithelial-mesenchymal transitions-to perform label-free surface marker screening of MCF10A, MCF-7, and Hs 578T breast epithelial cells. Our high-throughput, highly versatile technique enables rapid development of customized, antibody-based assays across a host of diverse diseases and research thrusts.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据